On the basis of GEO datasets, B-cell lymphoma 6 (BCL6) was identified as a target gene of miR-30 and involved in ibrutinib resistance of DLBCL, and cell experiment was consistent with the computational result [42]. This evidence concerns the gene BCL6 and diffuse large B-cell lymphoma.